Toxicity associated with tuberculosis chemotherapy in the REMoxTB study

about

Toxicity associated with tuberculosis chemotherapy in the REMoxTB study

Item

http://www.wikidata.org/entity/Q56969466

description

article

@en

wetenschappelijk artikel

@nl

наукова стаття, опублікована в липні 2018

@uk

name

Toxicity associated with tuberculosis chemotherapy in the REMoxTB study

@en

Toxicity associated with tuberculosis chemotherapy in the REMoxTB study

@nl

type

Item

label

Toxicity associated with tuberculosis chemotherapy in the REMoxTB study

@en

Toxicity associated with tuberculosis chemotherapy in the REMoxTB study

@nl

prefLabel

Toxicity associated with tuberculosis chemotherapy in the REMoxTB study

@en

Toxicity associated with tuberculosis chemotherapy in the REMoxTB study

@nl

P1476

Toxicity associated with tuberculosis chemotherapy in the REMoxTB study

@en

P2093

Andreas H Diacon

http://www.w3.org/2001/XMLSchema#string

Andrew J Nunn

http://www.w3.org/2001/XMLSchema#string

Angela M Crook

http://www.w3.org/2001/XMLSchema#string

Carl M Mendel

http://www.w3.org/2001/XMLSchema#string

Evans I Amukoye

http://www.w3.org/2001/XMLSchema#string

Genevieve H Wills

http://www.w3.org/2001/XMLSchema#string

Kasha P Singh

http://www.w3.org/2001/XMLSchema#string

Madeline Hanekom

http://www.w3.org/2001/XMLSchema#string

Melvin Spigelman

http://www.w3.org/2001/XMLSchema#string

Michael E Murphy

http://www.w3.org/2001/XMLSchema#string

P2860

Antituberculous drug-induced liver injury: current perspective

Health Seeking Behaviour among Tuberculosis Patients in India: A Systematic Review

Incidence of serious side effects from first-line antituberculosis drugs among patients treated for active tuberculosis

Adverse reactions to rifampicin in antituberculosis regimens

Factors associated with anti-tuberculosis medication adverse effects: a case-control study in Lima, Peru

Incidence and risk factors of serious adverse events during antituberculous treatment in Rwanda: a prospective cohort study

Statistical controversies in clinical research: Value of adverse events relatedness to study treatment: analyses of data from randomized double-blind placebo-controlled clinical trials.

The side effects and interactions of antituberculosis drugs.

Adverse effects of antituberculosis drugs.

Clinical deterioration during antituberculosis treatment in Africa: incidence, causes and risk factors.

P2888

s12879-018-3230-6

P304

317

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/S12879-018-3230-6

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Patrick Phillips

Conor D Tweed

P577

2018-07-11T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1105473887

http://www.w3.org/2001/XMLSchema#string

P698

29996783

http://www.w3.org/2001/XMLSchema#string

P921

infectious disease

chemotherapy

P932

6042413

http://www.w3.org/2001/XMLSchema#string